Grafa News and Videos — Page 150

Giftify (NASDAQ:GIFT) reported Q2 gross billings of $45.5 million, up 26.2%, while net sales increased 4.0% to $21.7 million.

Douglas Dynamics (NYSE:PLOW) announced its financial results for the second quarter of 2026, reporting record net sales of $214.6 million.

TG Therapeutics (NASDAQ:TGTX) reported Q2 global revenue of $240.3 million as U.S. BRIUMVI sales increased 64% to $227.7 million.

AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).

Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.

Ocular Therapeutix (NASDAQ:OCUL) reported Q2 revenue of $13.5 million and plans a Q4 AXPAXLI filing after FDA alignment.

Krystal Biotech (NASDAQ:KRYS) reported Q2 VYJUVEK revenue of $119.2 million, up 24%, and net income of $54.8 million.

Hess Midstream (NYSE:HESM) reported Q2 revenue of $399 million, net income of $173.7 million and adjusted free cash flow of $231.6 million.

Compugen (NASDAQ:CGEN) reported Q2 revenue of $2.6 million and said its $125.3 million cash position could fund operations into 2029.

Tyson Foods (NYSE:TSN) announced its financial results for the fiscal third quarter of 2026, reporting flat sales of $13.87 billion.